Search Results - "Calhoun, David"

Treatment of Resistant and Refractory Hypertension by Acelajado, Maria Czarina, Hughes, Zachary H, Oparil, Suzanne, Calhoun, David A

“…Resistant hypertension (RHTN) is defined as uncontrolled blood pressure despite the use of ≥3 antihypertensive agents of different classes, including a…”
Get full text

Resistant hypertension: incidence, prevalence, and prognosis by Pimenta, Eduardo, Calhoun, David A

Get full text

The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study by Brown, Jenifer M, Siddiqui, Mohammed, Calhoun, David A, Carey, Robert M, Hopkins, Paul N, Williams, Gordon H, Vaidya, Anand

“…Primary aldosteronism is a nonsuppressible renin-independent aldosterone production that causes hypertension and cardiovascular disease. To characterize the…”
Get full text

Hyperaldosteronism as a Common Cause of Resistant Hypertension by Calhoun, David A

“…Resistant hypertension affects an estimated 10-15 million American adults and is increasing in prevalence. The etiology of resistant hypertension is almost…”
Get full text

Resistant Hypertension: An Update of Experimental and Clinical Findings by Cai, Anping, Calhoun, David A

Get full text

Prevalence of Apparent Treatment-Resistant Hypertension in the United States: Comparison of the 2008 and 2018 American Heart Association Scientific Statements on Resistant Hypertension by Carey, Robert M, Sakhuja, Swati, Calhoun, David A, Whelton, Paul K, Muntner, Paul

“…In 2018, the American Heart Association published a Scientific Statement on resistant hypertension. We compared the prevalence of apparent treatment-resistant…”
Get full text

Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association by Carey, Robert M, Calhoun, David A, Bakris, George L, Brook, Robert D, Daugherty, Stacie L, Dennison-Himmelfarb, Cheryl R, Egan, Brent M, Flack, John M, Gidding, Samuel S, Judd, Eric, Lackland, Daniel T, Laffer, Cheryl L, Newton-Cheh, Christopher, Smith, Steven M, Taler, Sandra J, Textor, Stephen C, Turan, Tanya N, White, William B

“…Resistant hypertension (RH) is defined as above-goal elevated blood pressure (BP) in a patient despite the concurrent use of 3 antihypertensive drug classes,…”
Get full text

Medical Versus Surgical Treatment of Primary Aldosteronism by Calhoun, David A

Get full text

Paradoxical Increase of 24-Hour Urinary Aldosterone Levels in Obese Patients With Resistant Hypertension on a High Salt Diet by Dudenbostel, Tanja, Li, Peng, Calhoun, David A

“…Abstract BACKGROUND Having previously reported that aldosterone levels increase progressively with body mass index (BMI), the current analysis was done to…”
Get full text

Sleep and hypertension by Calhoun, David A, Harding, Susan M

“…Ambulatory BP studies indicate that even small increases in BP, particularly nighttime BP levels, are associated with significant increases in cardiovascular…”
Get more information

Refractory Hypertension: Evidence of Heightened Sympathetic Activity as a Cause of Antihypertensive Treatment Failure by Dudenbostel, Tanja, Acelajado, Maria C, Pisoni, Roberto, Li, Peng, Oparil, Suzanne, Calhoun, David A

“…Refractory hypertension is an extreme phenotype of treatment failure defined as uncontrolled blood pressure in spite of ≥5 classes of antihypertensive agents,…”
Get full text

Use of Aldosterone Antagonists for Treatment of Uncontrolled Resistant Hypertension by Dudenbostel, Tanja, Calhoun, David A

“…Multiple studies indicate that primary aldosteronism (PA) is common in patients with resistant hypertension, with an estimated prevalence of approximately 20%…”
Get full text

The Year in Clinical Hypertension From Other Pages by Calhoun, David A

Get full text

Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension by Sim, John J, Bhandari, Simran K, Shi, Jiaxiao, Reynolds, Kristi, Calhoun, David A, Kalantar-Zadeh, Kamyar, Jacobsen, Steven J

“…We sought to compare the risk of end-stage renal disease (ESRD), ischemic heart event (IHE), congestive heart failure (CHF), cerebrovascular accident (CVA),…”
Get more information

Refractory Hypertension: A Novel Phenotype of Antihypertensive Treatment Failure by Dudenbostel, Tanja, Siddiqui, Mohammed, Oparil, Suzanne, Calhoun, David A

Get full text

Renal Nerve Denervation, Adherence, and Management of Resistant Hypertension by Calhoun, David A

Get full text

Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension by Dudenbostel, Tanja, Ghazi, Lama, Liu, Mingchun, Li, Peng, Oparil, Suzanne, Calhoun, David A

“…Prospective studies indicate that hyperaldosteronism is found in 20% of patients with resistant hypertension. A small number of observational studies in…”
Get full text

Screening for Endocrine Hypertension: An Endocrine Society Scientific Statement by Young, William F., Calhoun, David A., Lenders, Jacques W.M., Stowasser, Michael, Textor, Stephen C.

“…Abstract Hypertension may be the initial clinical presentation for at least 15 endocrine disorders. An accurate diagnosis of endocrine hypertension provides…”
Get full text

Antihypertensive Medications and Falls in the Elderly by Cai, Anping, Calhoun, David A

Get full text

Scaling silicon photonic switch fabrics for data center interconnection networks by Nikolova, Dessislava, Rumley, Sébastien, Calhoun, David, Li, Qi, Hendry, Robert, Samadi, Payman, Bergman, Keren

“…With the rapidly increasing aggregate bandwidth requirements of data centers there is a growing interest in the insertion of optically interconnected networks…”
Get full text